• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

14
1
1
1

COUNTRY

1

CATEGORIES

  • 14
  • 7
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

1
18
19
43

PUBLISHED

0
0
4
43

PRODUCT TYPE

36
7

Search "TheraGenetics Inc. - Product Pipeline Analysis" returned 43 results.

PRODUCT TITLE

Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2013 Update

Summary Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The company undertakes the development and commercialization of small molecular diagnostic products. The company offers different...

April 2013
FROM

Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis

Summary Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The company undertakes the development and commercialization of small molecular diagnostic products. The company offers different...

November 2012
FROM
Expression Genetics, Inc. - Product Pipeline Review - Q4 2010 Expression Genetics, Inc. - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

Expression Genetics, Inc. - Product Pipeline Review - Q4 2010

Expression Genetics, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Expression Genetics, Inc. - Product Pipeline Review - Q4 2010” provides data on...

November 2010
FROM

Expression Genetics, Inc. - Product Pipeline Review - Q4 2010

Expression Genetics, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Expression Genetics, Inc. - Product Pipeline Review - Q4 2010” provides data on...

November 2010
FROM

Myriad Genetics, Inc. (MYGN) - Financial and Strategic SWOT Analysis Review

Myriad Genetics, Inc. (MYGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

January 2014
FROM
Companion Diagnostics - Global Strategic Business Report Companion Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Companion Diagnostics - Global Strategic Business Report

This report analyzes the worldwide markets for Companion Diagnostics in US$ Thousand The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

September 2011
FROM
Everist Genomics, Inc. - Product Pipeline Analysis Everist Genomics, Inc. - Product Pipeline Analysis - Product Thumbnail Image

Everist Genomics, Inc. - Product Pipeline Analysis

Everist Genomics, Inc. - Product Pipeline Analysis Summary Everist Genomics, Inc. (EGI), formerly Genetics Squared, Inc., is a privately held pharmaceutical company that is engaged in the development...

November 2011
FROM

Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2014 Update

Summary Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The company undertakes the discovery and commercialization of molecular diagnostic tests that assesses person’s risk towards...

May 2014
FROM

Alzheimer's Disease - Pipeline Review, H2 2013

'Alzheimer's Disease - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Alzheimer's Disease,...

August 2013
FROM

Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy This linkage could be important in the therapeutic...

June 2014
FROM

Stem Cell Markets

A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions...

August 2013
FROM

Follicular Lymphoma - Pipeline Review, H2 2013

Follicular Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Follicular Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM
Lymphoma - Pipeline Review, H1 2012 Lymphoma - Pipeline Review, H1 2012 - Product Thumbnail Image

Lymphoma - Pipeline Review, H1 2012

Lymphoma – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Lymphoma - Pipeline Review, H1 2012', provides an overview of the Lymphoma therapeutic pipeline. This report provides information...

January 2012
FROM
Bipolar Disorder - Global Strategic Business Report Bipolar Disorder - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder - Global Strategic Business Report

This report analyzes the worldwide markets for Bipolar Disorder in US$ Million The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific and Rest of World Annual estimates...

June 2010
FROM
Non-Hodgkin Lymphoma - Pipeline Review, H2 2012 Non-Hodgkin Lymphoma - Pipeline Review, H2 2012 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Review, H2 2012

Non-Hodgkin Lymphoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Non-Hodgkin Lymphoma - Pipeline Review, H2 2012', provides an overview of the Non-Hodgkin Lymphoma therapeutic pipeline....

August 2012
FROM
ADHD Therapeutics - Global Strategic Business Report ADHD Therapeutics - Global Strategic Business Report - Product Thumbnail Image

ADHD Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for ADHD Therapeutics in US$ Million The report provides separate comprehensive analytics for the US and Rest of World Annual estimates and forecasts are provided...

June 2010
FROM
Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015 Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015 - Product Thumbnail Image

Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015

Non-Hodgkin’s Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015 Summary GlobalData, the industry analysis specialist, has released a new report on the Pharmaceutical and Healthcare...

January 2010
FROM
Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peripheral Arterial Disease (PAD) Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Peripheral Arterial Disease (PAD) Therapeutics in US$ Million The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific,...

July 2012
FROM
Cancer Therapies - Global Strategic Business Report Cancer Therapies - Global Strategic Business Report - Product Thumbnail Image

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

October 2011
FROM
Hepatitis B - Pipeline Review, H2 2012 Hepatitis B - Pipeline Review, H2 2012 - Product Thumbnail Image

Hepatitis B - Pipeline Review, H2 2012

Hepatitis B – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Hepatitis B - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

November 2012
FROM
Loading Indicator

Our Clients

NBC Universal Inc. Samsung Group Ltd. E.ON SE DHL International GmbH University of Cambridge Kone Oyj BP Plc.